Core Insights - Interlink Electronics, Inc. has appointed Mark Duarte as the Director of Business Development for North America to support its organic growth strategy across the Americas [1][2] Group 1: Appointment and Role - Mark Duarte will play a crucial role in implementing Interlink's strategic growth plan and expanding its footprint across the Americas [2] - Duarte brings over 30 years of experience, including 22 years in sales and strategic planning, with a strong track record of exceeding revenue targets [3] Group 2: Previous Experience - Prior to joining Interlink, Duarte was the Senior Sales Manager at Linxens Healthcare, where he focused on aligning sales efforts with corporate growth strategies and secured multi-year contracts [3] - Duarte also served as the Director of Medical Sales at East West MFG., where he established the company as a premier contract manufacturer in the medical device market [4] Group 3: Company Overview - Interlink Electronics is a leading provider of sensor technology and printed electronic solutions, with 40 years of experience serving diverse markets including medical, industrial, automotive, and IoT [5] - The company operates from multiple locations, including its headquarters in Fremont, California, and manufacturing facilities in Shenzhen, China; Irvine, Scotland; and Barnsley, England [6]

Core Insights - Interlink Electronics, Inc. has appointed Darren Whittaker as the European Business Development Director to support its organic growth strategy in Europe [1] - Whittaker brings over 20 years of sales experience in high-tech sectors, having previously increased revenue by 8.3 times at Teledyne FLIR [2] - The company aims to drive significant growth across its technology offerings globally, as stated by CEO Steven Bronson [4] Company Overview - Interlink Electronics is a leader in sensor technology and printed electronics solutions, with 40 years of experience serving diverse markets including medical, industrial, automotive, wearables, and IoT [4] - The company operates from multiple locations, including its headquarters in Fremont, California, and manufacturing facilities in Shenzhen, China, Irvine, Scotland, and Barnsley, England [5] - Interlink's expertise encompasses materials science, manufacturing, embedded electronics, firmware, and software, allowing for tailored solutions for customers [4]

Partnerships & Integrations - Coinbase 选择 Chainlink 作为安全解决方案，将其 Coinbase Wrapped Assets 带到新的区块链上 [1] - 这被认为是朝着使加密货币领域更加统一迈出的巨大一步 [1] Technology & Adoption - 行业预测 2025 年将是 CCIP（Cross-Chain Interoperability Protocol 跨链互操作协议） 采用之年 [1] - 预计明年会有更多发展 [1]

RT XSwap 🔗 (@xswap_link)We’re super excited to take part in @chainlink Rewards Season 1.Eligible LINK stakers - big welcome to the XSwap community. It's time to allocate your Cubes.Let’s give you a closer look at what we’re building. 🧵 ...

Financial Performance - Revenue for Q3 2025 increased by 11% year-over-year to $3.0 million, compared to $2.7 million in Q3 2024[6] - Gross profit for Q3 2025 was $1.238 million, a 12% increase from $1.105 million in the same period last year[7] - Net loss for Q3 2025 improved to $336,000 from a net loss of $523,000 in Q3 2024[8] - Adjusted EBITDA for Q3 2025 was $(62,000), an improvement from $(248,000) in the prior-year period[9] - Revenue for Q3 2025 was $2,959,000, an increase of 10.8% compared to $2,671,000 in Q3 2024[22] - Gross profit for Q3 2025 was $1,238,000, up from $1,105,000 in Q3 2024, reflecting a gross margin improvement[22] - Net loss for Q3 2025 was $336,000, compared to a net loss of $523,000 in Q3 2024, indicating a reduction in losses[22] - Adjusted EBITDA for Q3 2025 was $(62,000), an improvement from $(248,000) in Q3 2024[25] - The company reported a net loss applicable to common stockholders of $436,000 in Q3 2025, down from $623,000 in Q3 2024[22] - Earnings per share for Q3 2025 was $(0.03), an improvement from $(0.04) in Q3 2024[22] Operational Highlights - The company secured two significant SBIR grants totaling $375,000 for advancing food safety technologies[6] - Interlink signed a Letter of Intent to acquire a U.K.-based engineering and manufacturing company, enhancing its European presence[6] - Total operating expenses for Q3 2025 were $1,551,000, slightly down from $1,581,000 in Q3 2024[22] - Engineering, research and development expenses decreased to $354,000 in Q3 2025 from $486,000 in Q3 2024, showing a focus on cost management[22] - Selling, general and administrative expenses increased to $1,197,000 in Q3 2025 from $1,095,000 in Q3 2024, indicating higher operational costs[22] Financial Position - Gross margin for Q3 2025 was 41.8%, a 40-basis-point increase from the previous year[8] - The company issued a 50% common stock dividend to enhance liquidity and shareholder value[4] - Total assets as of September 30, 2025, were $12.081 million, down from $13.116 million at the end of 2024[20] - Total stockholders' equity decreased to $9.632 million from $10.493 million at the end of 2024[20] - The weighted average common shares outstanding for Q3 2025 was 14,813,000, slightly up from 14,793,000 in Q3 2024[22]

Revenue Performance - Revenue for Q3 2025 was $2,959,000, representing a 10.8% increase from $2,671,000 in Q3 2024[112]. - For the nine months ended September 30, 2025, total revenue was $9,037,000, a 4.0% increase from $8,693,000 in the same period of 2024[123]. Profitability - Gross profit for Q3 2025 was $1,238,000, with a gross margin of 41.8%, up from $1,105,000 and 41.4% in Q3 2024[116]. - Gross profit for the nine months ended September 30, 2025, was $3,725,000, representing a gross margin of 41.2%, slightly down from 42.1% in 2024[124]. Market Segmentation - Medical market revenue increased by 88.9% to $1,084,000 in Q3 2025, while industrial market revenue decreased by 27.9% to $888,000[114]. - Medical market revenue decreased by 7.7% to $2,829,000, while industrial market revenue increased by 12.5% to $3,154,000[123]. Expenses - Engineering, research and development expenses decreased by 27.2% to $354,000 in Q3 2025, down from $486,000 in Q3 2024[117]. - Engineering, research and development expenses decreased by 26.8% to $1,572,000, accounting for 12.7% of revenue[125][127]. - Selling, general and administrative expenses increased by 9.3% to $1,197,000 in Q3 2025, compared to $1,095,000 in Q3 2024[118]. - Selling, general and administrative expenses were $3,670,000, or 40.6% of revenue, showing a slight increase of 1.1% compared to the previous year[128]. - Total operating expenses for Q3 2025 were $1,551,000, a decrease from $1,581,000 in Q3 2024[112]. Net Loss - The company reported a net loss of $336,000 in Q3 2025, compared to a net loss of $523,000 in Q3 2024[112]. Cash and Working Capital - As of September 30, 2025, the company had cash and cash equivalents of $3.0 million and working capital of $4.9 million, with no indebtedness[131]. - Net cash provided by operating activities was $244,000 for the nine months ended September 30, 2025, compared to a cash used of $144,000 in 2024[133][134]. Strategic Initiatives - The company has expanded its technology platforms through acquisitions, including Calman and Conductive Transfers, enhancing its product offerings in printed electronics and wearable technology[104]. - The company plans to explore strategic relationships with technology institutes to support growth initiatives[107]. - The company maintains a global presence with manufacturing facilities in Shenzhen, California, Scotland, and England, controlling 100% of the manufacturing and shipping process[106]. Other Income and Tax - Other income for the nine months ended September 30, 2025, was $33,000, compared to $29,000 in 2024, with interest income of $18,000 and foreign currency transaction gains of $15,000[129]. - Income tax expense was 2.1% of pre-tax income for the nine months ended September 30, 2025, down from 4.0% in 2024[130]. Stock Issuance - The company entered into an At-The-Market Issuance Sales Agreement allowing for the sale of up to $6,000,000 in common stock, with approximately $5.8 million available for sale as of September 30, 2025[138].

Core Insights - Interlink Electronics reported an 11% year-over-year revenue increase to $2.959 million for Q3 2025, marking the second consecutive quarter of double-digit growth [6][7][9] - The company is focusing on organic growth and has a strengthened M&A pipeline, positioning itself for transformative growth in 2026 [5][7] Financial Performance - Revenue for Q3 2025 was $2.959 million, up from $2.671 million in Q3 2024, driven by higher shipments of force-sensing products and printed electronics [6][8] - Gross profit increased to $1.238 million, a 12% rise from $1.105 million in the same quarter last year, with a gross margin of 41.8% [6][9] - The net loss for Q3 2025 was $336,000, an improvement from a net loss of $523,000 in Q3 2024 [6][9] Strategic Initiatives - The company converted all outstanding Series A Convertible Preferred Stock into common stock and issued a 50% common stock dividend, enhancing liquidity and shareholder alignment [4][7] - Interlink secured two significant U.S. government SBIR grants totaling $375,000 to advance food safety and quality monitoring technologies [3][7] - A Letter of Intent was signed to acquire a U.K.-based engineering and manufacturing company, expanding Interlink's European presence [7] Market Position and Outlook - Interlink is entering 2026 with strong momentum across product lines and a growing base of strategic partnerships, aiming for consistent profitability and scale [5][7] - The company continues to evaluate a growing pipeline of acquisition opportunities that align with long-term shareholder value [7]

Core Insights - UBS has completed the first on-chain redemption of a tokenized fund using Chainlink's Digital Transfer Agent, marking a significant step in integrating blockchain technology with the global fund industry valued at $100 trillion [1][2] - The transaction involved the UBS USD Money Market Investment Fund Token (uMINT), which is built on the Ethereum blockchain [1] - This achievement highlights the potential of smart contract-based technologies to enhance fund operations and improve the investor experience, according to UBS' group chief operating and technology officer [2][3] Industry Developments - The transaction is part of UBS Tokenize, the bank's platform for blockchain-based financial products, indicating a broader trend towards tokenized finance [3] - By automating functions such as order-taking, execution, and settlement, the technology aims to reduce operational complexity and processing time within the $100 trillion global fund industry [4] - A recent pilot project demonstrated Chainlink's ability to connect existing bank systems to blockchains via Swift, allowing banks to utilize blockchain technology without needing to overhaul their legacy systems [5]

.@SolvProtocol is enhancing their use of Chainlink CCIP for cross-chain SolvBTC transfers by incorporating @symbioticfi for additional cryptoeconomic guarantees.https://t.co/FEtdbrQCLqSymbiotic LINK and SOLV vaults will back a Symbiotic-powered network designed to monitor and flag potential anomalies when SolvBTC is transferred cross-chain.This development is made possible by CCIP’s extensive support for modular security, which enables token developers to incorporate additional custom safeguards into how th ...

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Cambium Networks Corporation (CMBM) has seen a remarkable increase of 306%, trading at $2.51 [3] - Teradyne, Inc. (TER) is up 21%, currently priced at $176.00 [3] - Bloom Energy Corporation (BE) has risen by 18%, trading at $134.50 [3] - Jamf Holding Corp. (JAMF) is up 15%, with a price of $12.85 [3] - CSG Systems International, Inc. (CSGS) has increased by 14%, trading at $79.00 [3] - Olympic Steel, Inc. (ZEUS) is also up 14%, currently priced at $34.20 [3] - Beta Bionics, Inc. (BBNX) has risen by 12%, trading at $27.20 [3] - Sonim Technologies, Inc. (SONM) is up 10%, currently priced at $12.49 [3] - Canadian Solar Inc. (CSIQ) has increased by 9%, trading at $16.67 [3] - Interlink Electronics, Inc. (LINK) is also up 9%, currently priced at $6.85 [3] Premarket Losers - Stride, Inc. (LRN) has experienced a significant decline of 41%, trading at $89.44 [4] - Varonis Systems, Inc. (VRNS) is down 29%, currently priced at $44.71 [4] - Akebia Therapeutics, Inc. (AKBA) has decreased by 26%, trading at $2.26 [4] - Avantor, Inc. (AVTR) is down 17%, currently priced at $12.40 [4] - GlucoTrack, Inc. (GCTK) has seen a decline of 13%, trading at $6.29 [4] - Tigo Energy, Inc. (TYGO) is down 13%, currently priced at $2.20 [4] - Generac Holdings Inc. (GNRC) has decreased by 9%, trading at $172.00 [4] - Polar Power, Inc. (POLA) is down 8%, currently priced at $3.71 [4] - Caesars Entertainment, Inc. (CZR) has seen a decline of 7%, trading at $20.50 [4] - Anteris Technologies Global Corp. (AVR) is also down 7%, currently priced at $4.46 [4]